Deep dives for pharma professionals
Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
How Geopolitical Risks Are Reshaping API Supply Chains
Market TrendsFrom Discovery to Preclinical Development: When Do Peptide Quality Requirements Need to Change?
Peptide Quality Requirements aren't fixed, they should scale with what the data needs to support, from discovery screening to GLP tox studies.
Market TrendsThe Reproducibility Problem in Peptide Research Starts Earlier Than Most Teams Think
The Reproducibility Problem in Peptide Research is usually decided at procurement, not in the lab. Here's what teams miss before the first experiment.
Market TrendsCapital Investments In Next-Generation Facilities Explained
Capital Investments In Next-Generation Facilities are turning pharma manufacturing into a top strategic priority, not a background function.
InnovationSilico Clinical Trials: Testing New Medicines In A Computer
Silico Clinical Trials use computer simulations and digital twins to predict drug behavior before real human trials begin.
Market TrendsDecentralized Manufacturing Models: Bringing Production Closer To The Patient
Decentralized Manufacturing Models spread production across smaller local sites instead of one factory. Here's how they work and what's still holding them back.
InnovationGenomic Sequencing For Contamination Investigations Explained
Genomic sequencing reads a pathogen's exact genetic fingerprint. Here's how it traces contamination to its source faster than ever before.
InnovationIsolator and RABS adoption curves in sterile fill-finish
Annex 1 is reshaping barrier technology choices, here's where isolator and RABS adoption stands, and why isolators are pulling ahead.
Continued Process Verification In Pharma: What Literature Shows
CPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.
How to Minimize Patent Rejection Setbacks with Access to Comprehensive Information
Patent rejections are costly and common, here's how proactive prior art searches and expert IP guidance help companies file stronger, faster.
Market TrendsUS Tariff Exposure By Manufacturing Footprint: A Sector Map
Learn how US pharmaceutical tariffs affect pharma manufacturers based on their manufacturing footprint, including India, APIs, generics, and onshoring.
Market TrendsCDMO Trends 2026: What’s Driving Mergers And Acquisitions
CDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.